Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

British Journal of Haematology, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15645?af=R

Source: British Journal of Haematology - November 26, 2018 Category: Hematology Authors: Michael Mian, Norbert Pescosta, Stefania Badiali, Paola Cristina Cappelletto, Luigi Marcheselli, Stefano Luminari, Francesca Patriarca, Renato Zambello, Anna Pascarella, Giuseppe Tagariello, Alessandra Marabese, Patrizia Mondello, Atto Billio, Tags: Correspondence Source Type: research